BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26084205)

  • 1. Survival of de novo and secondary acute promyelocytic leukemia: a propensity-matched analysis of the SEER database.
    Giri S; Pathak R; Martin MG; Bhatt VR
    Leuk Lymphoma; 2016 Feb; 57(2):385-391. PubMed ID: 26084205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
    Nasir SS; Giri S; Nunnery S; Martin MG
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Survival Outcomes Between De Novo and Secondary Acute Promyelocytic Leukemia: An Updated Population-based study.
    Tao Y; Yu YQ; Liu YY; Jia M; Gao L
    Clin Lymphoma Myeloma Leuk; 2022 Jan; 22(1):e7-e14. PubMed ID: 34462244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Overall Survival Between De Novo and Secondary Acute Lymphoblastic Leukemia Patients of Different Ages.
    Zhong J; Yu X; Zhang X
    Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):e622-e627. PubMed ID: 32565127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.
    Braun T; Cereja S; Chevret S; Raffoux E; Beaumont M; Detourmignies L; Pigneux A; Thomas X; Bordessoule D; Guerci A; Lamy T; Recher C; Poiré X; Tournilhac O; Spertini O; Chomienne C; Degos L; Dombret H; Adès L; Fenaux P;
    Cancer; 2015 Jul; 121(14):2393-9. PubMed ID: 25845577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of early death factors and prognosis of acute promyelocytic leukemia].
    Wu YX; Wu DP; Chen SN; Qiu HY; Han Y; Li CX; Ma X; Sun AN; Tang XW; Hu XH
    Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):1025-1030. PubMed ID: 33445851
    [No Abstract]   [Full Text] [Related]  

  • 7. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
    Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
    Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis.
    Giri S; Chi M; Johnson B; McCormick D; Jamy O; Bhatt VR; Martin MG
    Leuk Res; 2015 Dec; 39(12):1342-6. PubMed ID: 26427729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy.
    Elliott MA; Letendre L; Tefferi A; Hogan WJ; Hook C; Kaufmann SH; Pruthi RK; Pardanani A; Begna KH; Ashrani AA; Wolanskyj AP; Al-Kali A; Litzow MR
    Eur J Haematol; 2012 Mar; 88(3):237-43. PubMed ID: 22023492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci.
    Hasan SK; Ottone T; Schlenk RF; Xiao Y; Wiemels JL; Mitra ME; Bernasconi P; Di Raimondo F; Stanghellini MT; Marco P; Mays AN; Döhner H; Sanz MA; Amadori S; Grimwade D; Lo-Coco F
    Genes Chromosomes Cancer; 2010 Aug; 49(8):726-32. PubMed ID: 20544846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcome of childhood acute promyelocitic leukemia (APL) in Saudi Arabia: a multicenter SAPHOS leukemia group study.
    Jastaniah W; Alsultan A; Al Daama S; Ballourah W; Bayoumy M; Al-Anzi F; Al Shareef O; Abrar MB; Al Sudairy R; Al Ghemlas I
    Hematology; 2018 Jul; 23(6):316-323. PubMed ID: 29212418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database.
    Guru Murthy GS; Szabo A; Michaelis L; Carlson KS; Runaas L; Abedin S; Atallah E
    J Natl Compr Canc Netw; 2020 Feb; 18(2):169-175. PubMed ID: 32023530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of small bowel adenocarcinoma in Crohn's disease compares favourably with de novo small bowel adenocarcinoma.
    Wieghard N; Mongoue-Tchokote S; Young JI; Sheppard BC; Tsikitis VL
    Colorectal Dis; 2017 May; 19(5):446-455. PubMed ID: 27659145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early mortality and overall survival in acute promyelocytic leukemia: do real-world data match results of the clinical trials?
    Dhakal P; Lyden E; Rajasurya V; Zeidan AM; Chaulagain C; Gundabolu K; Bhatt VR
    Leuk Lymphoma; 2021 Aug; 62(8):1949-1957. PubMed ID: 33711907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide-based therapy is suitable for patients with psoriasis-associated acute promyelocytic leukemia - A retrospective clinical study.
    Ge F; Zhang Y; Cao F; Li J; Hou J; Wang P; Li H; Xu M; Liu S; Li L; Li X; Wang S; Lv C; Su Y; Zhou J
    Hematology; 2016 Jun; 21(5):287-94. PubMed ID: 26871996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience.
    Head DR; Kopecky KJ; Willman C; Appelbaum FR
    Leukemia; 1994; 8 Suppl 2():S38-41. PubMed ID: 7815835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission.
    Muchtar E; Vidal L; Ram R; Gafter-Gvili A; Shpilberg O; Raanani P
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009594. PubMed ID: 23543579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: Focus on DNA repair genes.
    Casorelli I; Tenedini E; Tagliafico E; Blasi MF; Giuliani A; Crescenzi M; Pelosi E; Testa U; Peschle C; Mele L; Diverio D; Breccia M; Lo-Coco F; Ferrari S; Bignami M
    Leukemia; 2006 Nov; 20(11):1978-88. PubMed ID: 16990782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia.
    Zhao H; Zhao Y; Zhang Y; Hou J; Yang H; Cao F; Yang Y; Hou W; Sun J; Jin B; Fu J; Li H; Wang P; Ge F; Zhou J
    Ann Hematol; 2018 Mar; 97(3):409-416. PubMed ID: 29289982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity burden and outcomes of older adults with acute promyelocytic leukemia: a National Cancer Database analysis of 2221 patients.
    Dhakal P; Lyden E; Joshi U; Pyakuryal A; Loh KP; Klepin H; Bhatt VR
    Leuk Lymphoma; 2023 Mar; 64(3):691-697. PubMed ID: 36629003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.